Bio-Rad Launches A Measles, Mumps, Rubella, And Varicella-Zoster Virus IgG Kit For Its BioPlex 2200 System
Main Category: Infectious Diseases / Bacteria / VirusesArticle Date: 25 May 2010 - 0:00 PST
'Bio-Rad Launches A Measles, Mumps, Rubella, And Varicella-Zoster Virus IgG Kit For Its BioPlex 2200 System'
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced the launch of the BioPlex® 2200 MMRV IgG kit for use on the company's BioPlex® 2200 system. The MMRV IgG kit (measles; mumps; rubella; and the varicella-zoster virus, which is commonly known as chicken pox) provides simultaneous results for the four tests that are commonly ordered together to determine a patient's susceptibility to MMRV.
The BioPlex 2200 MMRV IgG kit offers the advantage of multiplexing to deliver test results from a single patient sample. As a result, labs are able to generate test results quickly and with less effort. MMRV are infectious diseases that are preventable through vaccination. Maintaining high vaccination coverage and providing MMRV IgG results when an individual's status is uncertain is the most effective way to prevent disease outbreaks. Employees in healthcare facilities and military personnel, among others, are typically screened for MMRV IgG to ensure their safety.
"With the introduction of the BioPlex 2200 MMRV IgG kit, Bio-Rad offers a compelling menu for infectious disease serology and autoimmune testing laboratories," said John Goetz, Bio-Rad Vice President and Group Manager Clinical Diagnostics. "The MMRV IgG kit is the latest in our expanding menu of assays that run on our BioPlex 2200 system."
The BioPlex 2200 system is the first and only fully-automated, random access multiplex testing system and provides clinical laboratories with the capability to rapidly process or "multiplex" multiple individual tests that are traditionally processed separately. The BioPlex 2200 system conserves patient sample volume, consolidates workstations, and simplifies workflow.
Source
Bio-Rad Laboratories, Inc.
Visit our infectious diseases / bacteria / viruses section for the latest news on this subject.
MLA
25 May. 2012. <http://www.medicalnewstoday.com/releases/189708.php>
APA
http://www.medicalnewstoday.com/releases/189708.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Bio-Rad Launches A Measles, Mumps, Rubella, And Varicella-Zoster Virus IgG Kit For Its BioPlex 2200 System'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




